Prognostic Value of Vascular Endothelial Growth Factor Tumor Tissue Content of Colorectal Cancer
Authors:
- Patrizia FerroniPFPatrizia Ferroni
- Antonella SpilaASAntonella Spila
- Francesca MartiniFMFrancesca Martini
- Roberta D’aLessandroRDRoberta D’aLessandro
- Sabrina MariottiSMSabrina Mariotti
- Girolamo Del MonteGMGirolamo Del Monte
- Paolo GrazianoPGPaolo Graziano
- Oreste BuonomoOBOreste Buonomo
- Fiorella GuadagniFGFiorella Guadagni
- Mario RoselliMRMario Roselli
- 1 September 2005
- journal article
- Published by S. Karger AG in Oncology
- Vol. 69 (2) , 145-153
Abstract
Objectives: A longitudinal study was designed to quantify tumor tissue content of vascular endothelial growth factor (VEGF) in patients with colorectal cancer (CRC) and to evaluate its prognostic value in respect to the relapse-free and overall survivals. Methods: Sixty-nine patients with CRC were followed from the time of diagnosis of primary tumor for at least 3 years after surgery. Quantitative evaluation of VEGF content in tissue was performed on whole protein extracts obtained from biopsies of histologically confirmed neoplastic tissues and corresponding mucosa, histologically confirmed as ‘normal’. Results: VEGF levels were higher in CRC tissues, median 141 pg/mg of protein (interquartile range 70–375), compared with corresponding normal mucosa, median 45 pg/mg of protein (interquartile range 22–78; p < 0.0001), and were associated with the stage of disease (p = 0.035) by multivariate analysis. Tumor VEGF content was higher in relapsing patients compared with those who remained disease free (p < 0.001) and was independently associated with relapse-free survival (p = 0.044). Cox’s proportional hazard survival analysis demonstrated that VEGF (p = 0.035) had an independent prognostic value in respect to overall survival. Conclusions: Elevated tumor VEGF content may discriminate between early and late stages of CRC and may be used as an independent prognostic parameter in the management of these patients.Keywords
This publication has 23 references indexed in Scilit:
- Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridizationThe Journal of Pathology, 2003
- The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progressionThe Journal of Pathology, 2003
- Biology of angiogenesis in tumors of the gastrointestinal tractMicroscopy Research and Technique, 2003
- Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinomaWorld Journal of Gastroenterology, 2003
- Role of biological markers in the clinical outcome of colon cancerBritish Journal of Cancer, 2002
- Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancerAmerican Journal of Hematology, 2002
- Prognostic value of vascular endothelial growth factor expression in colorectal cancer patientsEuropean Journal of Cancer, 2000
- Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progressionInternational Journal of Cancer, 1999
- Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancerBritish Journal of Cancer, 1998
- Categorising continuous variablesBritish Journal of Cancer, 1991